These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25962985)

  • 1. Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder.
    Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2016 Feb; 266(1):83-5. PubMed ID: 25962985
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of suicidal depression with ketamine in rapid cycling bipolar disorder.
    Sampath H; Sharma I; Dutta S
    Asia Pac Psychiatry; 2016 Mar; 8(1):98-101. PubMed ID: 26871425
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined ketamine/transcranial magnetic stimulation treatment of severe depression in bipolar I disorder.
    Best SR
    J ECT; 2014 Dec; 30(4):e50-1. PubMed ID: 25054363
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression.
    Cusin C; Hilton GQ; Nierenberg AA; Fava M
    Am J Psychiatry; 2012 Aug; 169(8):868-9. PubMed ID: 22854933
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine and Other Glutamate Receptor Modulators for Depression in Bipolar Disorder in Adults.
    van Wissen K; Blanchard D
    Issues Ment Health Nurs; 2017 Jun; 38(6):526-527. PubMed ID: 28605240
    [No Abstract]   [Full Text] [Related]  

  • 6. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 7. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression.
    Permoda-Osip A; Dorszewska J; Bartkowska-Sniatkowska A; Chlopocka-Wozniak M; Rybakowski JK
    Pharmacopsychiatry; 2013 Sep; 46(6):227-8. PubMed ID: 23846402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types.
    Dacquino C; De Rossi P; Spalletta G
    Clin Chim Acta; 2015 Sep; 449():49-59. PubMed ID: 25704299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder.
    Kasteng F; Eriksson J; Sennfält K; Lindgren P
    Acta Psychiatr Scand; 2011 Sep; 124(3):214-25. PubMed ID: 21609324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug efficacy and diagnostic specificity in manic depressive illness and schizophrenia.
    Hekimian LJ; Gershon S; Hardesty AS; Burdock EI
    Dis Nerv Syst; 1969 Nov; 30(11):747-51. PubMed ID: 5359047
    [No Abstract]   [Full Text] [Related]  

  • 13. Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia.
    Mamdani F; Martin MV; Lencz T; Rollins B; Robinson DG; Moon EA; Malhotra AK; Vawter MP
    Dis Markers; 2013; 35(1):11-21. PubMed ID: 24167345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine and phencyclidine: the good, the bad and the unexpected.
    Lodge D; Mercier MS
    Br J Pharmacol; 2015 Sep; 172(17):4254-76. PubMed ID: 26075331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cariprazine (Vraylar) for schizophrenia and bipolar I disorder.
    Med Lett Drugs Ther; 2016 Apr; 58(1493):51-3. PubMed ID: 27101209
    [No Abstract]   [Full Text] [Related]  

  • 16. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D; Ozdel O; Sözeri-Varma G; Kıroğlu Y; Tümkaya S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):176-81. PubMed ID: 22306485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
    Krystal JH; D'Souza DC; Mathalon D; Perry E; Belger A; Hoffman R
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):215-33. PubMed ID: 12955285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
    Kimoto S; Zaki MM; Bazmi HH; Lewis DA
    JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach.
    Pinto JV; Passos IC; Gomes F; Reckziegel R; Kapczinski F; Mwangi B; Kauer-Sant'Anna M
    Schizophr Res; 2017 Oct; 188():182-184. PubMed ID: 28110815
    [No Abstract]   [Full Text] [Related]  

  • 20. T2 relaxation time abnormalities in bipolar disorder and schizophrenia.
    Ongür D; Prescot AP; Jensen JE; Rouse ED; Cohen BM; Renshaw PF; Olson DP
    Magn Reson Med; 2010 Jan; 63(1):1-8. PubMed ID: 19918902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.